Ontology highlight
ABSTRACT: Background
Acute moderate-to-severe steroid-refractory ulcerative colitis (UC) has a poor prognosis and requires optimal rescue therapy. A pooled analysis was conducted to assess tacrolimus and infliximab (IFX) as rescue agents in patients with moderate-to-severe and steroid-refractory UC.Methods
A literature search identified studies that investigated tacrolimus and IFX in moderate-to-severe steroid-refractory patients with UC. The primary outcome was short-term clinical response to treatment, including the remission and response rates. Secondary outcomes included the rates of colectomy at 3 months and adverse events rate.Results
A total of 6 studies comprising 438 cases were eligible for inclusion. The pooled analysis showed that the short-term clinical response r
SUBMITTER: Liu YJ
PROVIDER: S-EPMC6133612 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature